Explain this page
Arphra AIPlain-English read on GE HealthCare Technologies Inc.’s valuationAI Issuer Brief
Arphra AILoading cached brief…
Fair value
Football field →Weighted blend
$83.95
+29.81% vs spot
Recommendation
Strong Buy
20 of 21 methods
Method spread
9bull10bear
±5% threshold
Analyst PT consensus: $84.00 (+29.89%)
Price change · trailing returns
Live| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00% | +3.26% | +1.89% | -14.49% | -22.11% | -21.15% | -9.77% | -16.12% | +7.78% | +7.78% | +7.78% |
Insider · 30d
History →Bought
$5.78M
7 txns
Sold
$573.29K
3 txns
Net flow
+$5.21M
Aftermarket
LiveLast trade
$65.03
Bid
$64.72
20 sh
Ask
$65.03
100 sh
Spread
$0.310
Recent quarters
All financials →| Period | Revenue | Net income | EPS |
|---|---|---|---|
| Q1 Mar 2026 | $5.13B | $389M | $0.85 |
| Q4 Dec 2025 | $4.67B | $184M | $0.38 |
| Q3 Sep 2025 | $5.14B | $446M | $0.98 |
| Q2 Jun 2025 | $5.01B | $486M | $1.06 |
| Q1 Mar 2025 | $4.78B | $564M | $1.23 |
| Q4 Dec 2024 | $5.32B | $720M | $1.57 |
Sector & industry today
LiveSectors
- Communication Services+0.40%
- Financial Services+0.18%
- Energy+0.01%
- Technology-0.07%
- Consumer Cyclical-0.13%
- Consumer Defensive-0.45%
- Healthcare-0.50%
- Industrials-0.73%
- Basic Materials-1.36%
- Utilities-1.53%
- Real Estate-1.58%
Top industries (issuer's industry highlighted)
- Medical - Healthcare Information Services-2.58%
- Solar-6.96%
- REIT - Healthcare Facilities-3.27%
- Construction Materials-3.10%
- Copper-3.02%
- Biotechnology-2.86%
- Financial - Mortgages-2.51%
- Software - Infrastructure-2.48%
- Security & Protection Services-2.31%
- Electrical Equipment & Parts-2.27%
- REIT - Specialty-2.22%
- Trucking+2.20%
Analyst view
DB · price_targets + analyst_gradesConsensus target
$84.00
+29.89% upside
Low
$65.00
Median
$85.00
High
$105.00
Recent actions
0 ↑0 ↓8 hold
- May 01, 2026
- Apr 01, 2026
- Mar 01, 2026
- Feb 01, 2026
- Jan 01, 2026
News
DB · news_items- GE HealthCare Gains FDA Clearance for AI Radiation Planning Softwarezacks.com·Jun 05, 2026
- GE HealthCare receives FDA 510(k) clearance for MIM Contour ProtégéAI+ 2.0, advancing AI-enabled radiation therapy planning with expanded clinical capabilitiesbusinesswire.com·Jun 04, 2026
- GE HealthCare receives FDA 510(k) clearance for MIM Contour ProtégéAI+ 2.0, advancing AI-enabled radiation therapy planning with expanded clinical capabilitiesbusinesswire.com·Jun 04, 2026
- GE HealthCare Technologies Inc. (GEHC) Presents at Jefferies Global Healthcare Conference 2026 Transcriptseekingalpha.com·Jun 03, 2026
- GE HealthCare Technologies Inc. (GEHC) Presents at Bank of America Global Healthcare Conference 2026 Transcriptseekingalpha.com·May 12, 2026
- GE HealthCare Expands SIGNA MR Portfolio With AI-Powered Toolszacks.com·May 12, 2026
- GE HealthCare next-gen SIGNA MR technology helps advance research discovery and translate innovation into clinical impactbusinesswire.com·May 11, 2026
- INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of GE HealthCare Technologies Inc. - GEHCprnewswire.com·May 07, 2026
Recent analyst activity
DB- Jun 08, 2026GradeNeutral → NeutralGoldman Sachs Reiterates Neutral Rating on GE HealthCare (GEHC) Post Management MeetGoldman Sachs
Peers
Total assets
$36.91B
Total debt
$10B
Cash & equiv
$4.51B
Operating CF
$1.99B
Free cash flow
$1.51B
Buybacks
-$200M
Recent insiders
All →| Insider | Action | Shares | Value | Date |
|---|---|---|---|---|
Hochman Rodney F director | Buy | 1,618 | $100.36K | May 12, 2026 |
Yang Watkin Phoebe L. director | Buy | 1,000 | $63.01K | May 08, 2026 |
Stromberg William J director | Buy | 1,000 | $61.69K | May 06, 2026 |
CULP H LAWRENCE JR director | Buy | 80,805 | $5M | May 06, 2026 |
SACCARO JAMES officer: Chief Financial Officer | Buy | 3,310 | $200.59K | May 01, 2026 |
Jimenez Frank R officer: GC & Corporate Secretary | Buy | 1,750 | $105.79K | Apr 30, 2026 |
Income statement · annual
5y| Period | Revenue | Op income | Net income | EPS | Net margin |
|---|---|---|---|---|---|
| FY 2025 | $20.63B | $2.76B | $2.08B | $4.55 | +10.10% |
| FY 2024 | $19.67B | $2.63B | $1.99B | $4.34 | +10.13% |
| FY 2023 | $19.55B | $2.44B | $1.57B | $3.02 | +8.02% |
| FY 2022 | $18.34B | $2.52B | $1.92B | $4.22 | +10.45% |
| FY 2021 | $17.59B | $2.8B | $2.25B | $4.90 | +12.78% |